ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

PMD Psychemedics Corporation

2,55
-0,0863 (-3,27%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Psychemedics Corporation PMD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,0863 -3,27% 2,55 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,64 2,53 2,64 2,55 2,6363
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
28/3/202413:20GLOBEPsychemedics Corporation Reports 2023 Financial Results
21/3/202414:00GLOBEPsychemedics Recognized as a Top 10 Employee Health Testing..
13/2/202415:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202422:10EDGAR2Form 8-K - Current report
24/1/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202417:27GLOBEPsychemedics Corporation Announces Relocation of..
19/12/202322:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/12/202318:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/11/202317:31EDGAR2Form 8-K - Current report
27/11/202315:00GLOBEPsychemedics Corporation Appoints Daniella Mehalik as VP -..
13/11/202323:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:00GLOBEPsychemedics Corporation Reports Third Quarter 2023..
09/11/202323:00EDGAR2Form 8-K - Current report
08/11/202323:00EDGAR2Form 8-K - Current report
27/10/202317:00GLOBEUnveiling the Future of Drug Testing: Psychemedics..
26/9/202300:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202319:00EDGAR2Form 8-K - Current report
21/9/202323:00GLOBEPsychemedics Corporation Appoints Shannon Shoemaker as Chief..
31/8/202323:20EDGAR2Form 8-K - Current report
22/8/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202323:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/8/202323:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:01EDGAR2Form 8-K - Current report
18/8/202320:00GLOBEPsychemedics Corporation Reports Inducement Grants Under..
17/8/202323:30EDGAR2Form 144 - Report of proposed sale of securities
14/8/202323:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202323:10GLOBEPsychemedics Corporation Reports Second Quarter 2023..
11/8/202323:10EDGAR2Form 8-K - Current report
21/7/202323:00EDGAR2Form 8-K - Current report
21/7/202322:00EDGAR2Form DEF 14A - Other definitive proxy statements
14/7/202315:15EDGAR2Form 8-K - Current report
12/7/202323:15GLOBEPsychemedics Corporation Announces CEO Succession Plan
09/5/202323:30GLOBEPsychemedics Corporation Reports First Quarter 2023..

Dernières Valeurs Consultées

Delayed Upgrade Clock